• Contact Us
PAVmed Inc. - Innovating at the speed of life. PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact
PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • NASDAQ: PAVM
    • NASDAQ: PAVMZ
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer

Nov 09, 2022 8:25am EST

PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022

Nov 03, 2022 8:25am EDT

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022

Nov 02, 2022 8:25am EDT

PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference

Aug 30, 2022 8:25am EDT

PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results

Aug 16, 2022 4:40pm EDT

Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results

Aug 15, 2022 4:25pm EDT

Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio

Aug 11, 2022 8:25am EDT

Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies

Aug 04, 2022 8:25am EDT

PAVmed to Hold a Business Update Conference Call on August 16, 2022

Aug 03, 2022 8:25am EDT

Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements

Aug 02, 2022 8:25am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...23
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    About PAVmed Inc.

    PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

    Follow Us

    PAVmed Inc

    One Grand Central Place, Suite 4600
    New York, NY 10165
    212-949-4319
    info@pavmed.com


    PAVmed Inc. - Innovating at the speed of life.
    © Copyright 2023. All Rights Reserved by PAVmed Inc. .
    • News
    • Contact
    • Privacy Policy
    For more information regarding the proposed terms of settlement of a pending class action lawsuit, please click here.